Boston, MA
Summary
This business specializes in developing tools for programming living cells, integrating synthetic biology with computer-aided design to enhance therapeutic applications. They offer an end-to-end platform that includes engineered host cells, a genetic parts library, and cloud-based design software for creating and optimizing genetic systems. Their focus areas include biologics, gene therapy production, and programmable medicines, catering to biotech companies and pharmaceutical industries.
Based on content on asimov.com
culturebiosciences.com
San Francisco, CA
Biotechnology and bioprocess development.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
26.1 years — Since Dec 1998
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
541715
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Synthetic Biology and Biotechnology
2. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Vendor
Source
Microsoft
TXT Record
TXT Record
Pardot
TXT Record
Sendgrid
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1998 |
|
|
|
|
|
|
|
|
|
|
|
|
| 1999 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2000 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2001 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2002 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2003 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2009 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|